China may have just delivered some very unwelcome news to drug makers Merck and Janssen, the vaccines division of Johnson & Johnson.
As those companies and public health officials race to test experimental Ebola vaccines in the Democratic Republic of Congo before its outbreak is extinguished, the Chinese have signaled that they may also try to use their own experimental product there.
About the Author Reprints
